Sanjeev Sewak

482 total citations
11 papers, 90 citations indexed

About

Sanjeev Sewak is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sanjeev Sewak has authored 11 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Sanjeev Sewak's work include Prostate Cancer Treatment and Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Sanjeev Sewak is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Sanjeev Sewak collaborates with scholars based in Australia, United States and Austria. Sanjeev Sewak's co-authors include Franco M. Muggia, David Zagzag, Joan Sorich, Howard S. Höchster, Stuart G. Marcus, Elliot Newman, Herman Yee, M Potmĕsil, Peter Graham and Margaret J. Henry and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Gastrointestinal Surgery and Journal of Neuro-Oncology.

In The Last Decade

Sanjeev Sewak

10 papers receiving 85 citations

Peers

Sanjeev Sewak

PRM

ONCOL

SURGE

GASTR

Santiago Soto Spain

Eduardo Cronemberger Brazil

Xinqun Chen Japan

Foysal Daian United States

Jay Zeck United States

A. Poveda Velasco Spain

Piotr Wandzel Poland

Noah Theiss United States

Enxiao Li China

Kathia Cristina Abdalla Brazil

Santiago Soto Spain

Sanjeev Sewak

51 ×0.9

PRM

64 ×1.5

ONCOL

34 ×1.5

SURGE

9 ×0.6

GASTR

7 ×0.6

Citations per year, relative to Sanjeev Sewak Sanjeev Sewak (= 1×) peers Santiago Soto

Countries citing papers authored by Sanjeev Sewak

Since Specialization

Citations

This map shows the geographic impact of Sanjeev Sewak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeev Sewak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeev Sewak more than expected).

Fields of papers citing papers by Sanjeev Sewak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjeev Sewak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeev Sewak. The network helps show where Sanjeev Sewak may publish in the future.

Co-authorship network of co-authors of Sanjeev Sewak

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjeev Sewak. A scholar is included among the top collaborators of Sanjeev Sewak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjeev Sewak. Sanjeev Sewak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Souza, Paul L. de, Shirley Wong, Sanjeev Sewak, et al.. (2018). Phase II study of sequential first-line pazopanib (PAZ) followed by everolimus (EVE) in patients (pts) with advanced or metastatic renal cell carcinoma (RCC) (CATChEz Study).. Journal of Clinical Oncology. 36(6_suppl). 648–648. 1 indexed citations

Lomax, Anna J., Karen White, Jane Beith, et al.. (2013). Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial. Journal of bone oncology. 2(4). 145–153. 19 indexed citations

Sewak, Sanjeev, Suzanne Kosmider, Vinod Ganju, et al.. (2009). Phase II study of paclitaxel and vinorelbine (Pacl‐Vin) in hormone‐refractory metastatic prostate cancer: double tubulin targeting. Internal Medicine Journal. 40(3). 201–208. 3 indexed citations

Yap, Cheng‐Hon, et al.. (2007). Resection of Right Atrial Metastatic Large-Cell Neuroendocrine Carcinoma. Asian Cardiovascular and Thoracic Annals. 15(1). e20–e22. 1 indexed citations

Sewak, Sanjeev, Suzanne Kosmider, Vinod Ganju, et al.. (2007). A phase II study of paclitaxel and vinorelbine (Pac-Vin) in hormone-refractory metastatic prostate cancer (HRPC): A final update. Journal of Clinical Oncology. 25(18_suppl). 15505–15505. 1 indexed citations

Sewak, Sanjeev, et al.. (2006). Phase I trial of continuous infusion 9-aminocamptothecin in patients with advanced solid tumors: 21-day infusion is an active well-tolerated regimen. Anti-Cancer Drugs. 17(5). 571–579. 2 indexed citations

Haigentz, Missak, Mimi Kim, Joan Sorich, et al.. (2003). Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies. Anti-Cancer Drugs. 14(4). 321–326. 4 indexed citations

Sewak, Sanjeev, Abraham Chachoua, Anne Hamilton, et al.. (2003). A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting. Anti-Cancer Drugs. 14(1). 67–72. 6 indexed citations

Sewak, Sanjeev, Franco M. Muggia, & David Zagzag. (2002). Endometrial Carcinoma with Cerebellar Metastasis: A Case Report and Review of the Literature. Journal of Neuro-Oncology. 58(2). 137–140. 17 indexed citations

10.

Newman, Elliot, Stuart G. Marcus, M Potmĕsil, et al.. (2002). Neoadjuvant Chemotherapy with CPT-11 and Cisplatin Downstages Locally Advanced Gastric Cancer. Journal of Gastrointestinal Surgery. 6(2). 212–223. 31 indexed citations

11.

Sewak, Sanjeev, et al.. (1999). Tattoo allergy in patients receiving adjuvant radiotherapy for breast cancer. Australasian Radiology. 43(4). 558–561. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact